Global Dermatomycoses Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dermatomycoses Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Dermatomycoses Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Dermatomycoses Drug by Country/Region, 2017, 2022 & 2028

2.2 Dermatomycoses Drug Segment by Type

2.2.1 BB-2603

2.2.2 Clotrimazole

2.2.3 Dapaconazole

2.2.4 Others

2.3 Dermatomycoses Drug Sales by Type

2.3.1 Global Dermatomycoses Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Dermatomycoses Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Dermatomycoses Drug Sale Price by Type (2017-2022)

2.4 Dermatomycoses Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Dermatomycoses Drug Sales by Application

2.5.1 Global Dermatomycoses Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Dermatomycoses Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Dermatomycoses Drug Sale Price by Application (2017-2022)

3 Global Dermatomycoses Drug by Company

3.1 Global Dermatomycoses Drug Breakdown Data by Company

3.1.1 Global Dermatomycoses Drug Annual Sales by Company (2020-2022)

3.1.2 Global Dermatomycoses Drug Sales Market Share by Company (2020-2022)

3.2 Global Dermatomycoses Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Dermatomycoses Drug Revenue by Company (2020-2022)

3.2.2 Global Dermatomycoses Drug Revenue Market Share by Company (2020-2022)

3.3 Global Dermatomycoses Drug Sale Price by Company

3.4 Key Manufacturers Dermatomycoses Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dermatomycoses Drug Product Location Distribution

3.4.2 Players Dermatomycoses Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Dermatomycoses Drug by Geographic Region

4.1 World Historic Dermatomycoses Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Dermatomycoses Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Dermatomycoses Drug Annual Revenue by Geographic Region

4.2 World Historic Dermatomycoses Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Dermatomycoses Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Dermatomycoses Drug Annual Revenue by Country/Region

4.3 Americas Dermatomycoses Drug Sales Growth

4.4 APAC Dermatomycoses Drug Sales Growth

4.5 Europe Dermatomycoses Drug Sales Growth

4.6 Middle East & Africa Dermatomycoses Drug Sales Growth

5 Americas

5.1 Americas Dermatomycoses Drug Sales by Country

5.1.1 Americas Dermatomycoses Drug Sales by Country (2017-2022)

5.1.2 Americas Dermatomycoses Drug Revenue by Country (2017-2022)

5.2 Americas Dermatomycoses Drug Sales by Type

5.3 Americas Dermatomycoses Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dermatomycoses Drug Sales by Region

6.1.1 APAC Dermatomycoses Drug Sales by Region (2017-2022)

6.1.2 APAC Dermatomycoses Drug Revenue by Region (2017-2022)

6.2 APAC Dermatomycoses Drug Sales by Type

6.3 APAC Dermatomycoses Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Dermatomycoses Drug by Country

7.1.1 Europe Dermatomycoses Drug Sales by Country (2017-2022)

7.1.2 Europe Dermatomycoses Drug Revenue by Country (2017-2022)

7.2 Europe Dermatomycoses Drug Sales by Type

7.3 Europe Dermatomycoses Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dermatomycoses Drug by Country

8.1.1 Middle East & Africa Dermatomycoses Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Dermatomycoses Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Dermatomycoses Drug Sales by Type

8.3 Middle East & Africa Dermatomycoses Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Dermatomycoses Drug

10.3 Manufacturing Process Analysis of Dermatomycoses Drug

10.4 Industry Chain Structure of Dermatomycoses Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Dermatomycoses Drug Distributors

11.3 Dermatomycoses Drug Customer

12 World Forecast Review for Dermatomycoses Drug by Geographic Region

12.1 Global Dermatomycoses Drug Market Size Forecast by Region

12.1.1 Global Dermatomycoses Drug Forecast by Region (2023-2028)

12.1.2 Global Dermatomycoses Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Dermatomycoses Drug Forecast by Type

12.7 Global Dermatomycoses Drug Forecast by Application

13 Key Players Analysis

13.1 Anacor Pharmaceuticals Inc

13.1.1 Anacor Pharmaceuticals Inc Company Information

13.1.2 Anacor Pharmaceuticals Inc Dermatomycoses Drug Product Offered

13.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Anacor Pharmaceuticals Inc Main Business Overview

13.1.5 Anacor Pharmaceuticals Inc Latest Developments

13.2 Biolab Farmaceutica Ltda

13.2.1 Biolab Farmaceutica Ltda Company Information

13.2.2 Biolab Farmaceutica Ltda Dermatomycoses Drug Product Offered

13.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biolab Farmaceutica Ltda Main Business Overview

13.2.5 Biolab Farmaceutica Ltda Latest Developments

13.3 Blueberry Therapeutics Ltd

13.3.1 Blueberry Therapeutics Ltd Company Information

13.3.2 Blueberry Therapeutics Ltd Dermatomycoses Drug Product Offered

13.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Blueberry Therapeutics Ltd Main Business Overview

13.3.5 Blueberry Therapeutics Ltd Latest Developments

13.4 Daewoong Pharmaceutical Co Ltd

13.4.1 Daewoong Pharmaceutical Co Ltd Company Information

13.4.2 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product Offered

13.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Daewoong Pharmaceutical Co Ltd Main Business Overview

13.4.5 Daewoong Pharmaceutical Co Ltd Latest Developments

13.5 Dermala Inc

13.5.1 Dermala Inc Company Information

13.5.2 Dermala Inc Dermatomycoses Drug Product Offered

13.5.3 Dermala Inc Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Dermala Inc Main Business Overview

13.5.5 Dermala Inc Latest Developments

13.6 Helix BioMedix Inc

13.6.1 Helix BioMedix Inc Company Information

13.6.2 Helix BioMedix Inc Dermatomycoses Drug Product Offered

13.6.3 Helix BioMedix Inc Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Helix BioMedix Inc Main Business Overview

13.6.5 Helix BioMedix Inc Latest Developments

13.7 Novan Inc

13.7.1 Novan Inc Company Information

13.7.2 Novan Inc Dermatomycoses Drug Product Offered

13.7.3 Novan Inc Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novan Inc Main Business Overview

13.7.5 Novan Inc Latest Developments

13.8 Sol-Gel Technologies Ltd

13.8.1 Sol-Gel Technologies Ltd Company Information

13.8.2 Sol-Gel Technologies Ltd Dermatomycoses Drug Product Offered

13.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sol-Gel Technologies Ltd Main Business Overview

13.8.5 Sol-Gel Technologies Ltd Latest Developments

13.9 TGV-Laboratories

13.9.1 TGV-Laboratories Company Information

13.9.2 TGV-Laboratories Dermatomycoses Drug Product Offered

13.9.3 TGV-Laboratories Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 TGV-Laboratories Main Business Overview

13.9.5 TGV-Laboratories Latest Developments

13.10 Viamet Pharmaceuticals Inc

13.10.1 Viamet Pharmaceuticals Inc Company Information

13.10.2 Viamet Pharmaceuticals Inc Dermatomycoses Drug Product Offered

13.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Viamet Pharmaceuticals Inc Main Business Overview

13.10.5 Viamet Pharmaceuticals Inc Latest Developments

13.11 Vyome Biosciences Pvt Ltd

13.11.1 Vyome Biosciences Pvt Ltd Company Information

13.11.2 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product Offered

13.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Vyome Biosciences Pvt Ltd Main Business Overview

13.11.5 Vyome Biosciences Pvt Ltd Latest Developments

14 Research Findings and Conclusion

Table 1. Dermatomycoses Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Dermatomycoses Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of BB-2603

Table 4. Major Players of Clotrimazole

Table 5. Major Players of Dapaconazole

Table 6. Major Players of Others

Table 7. Global Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)

Table 8. Global Dermatomycoses Drug Sales Market Share by Type (2017-2022)

Table 9. Global Dermatomycoses Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Dermatomycoses Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Dermatomycoses Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)

Table 13. Global Dermatomycoses Drug Sales Market Share by Application (2017-2022)

Table 14. Global Dermatomycoses Drug Revenue by Application (2017-2022)

Table 15. Global Dermatomycoses Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Dermatomycoses Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Dermatomycoses Drug Sales by Company (2020-2022) & (K Units)

Table 18. Global Dermatomycoses Drug Sales Market Share by Company (2020-2022)

Table 19. Global Dermatomycoses Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Dermatomycoses Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Dermatomycoses Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Dermatomycoses Drug Producing Area Distribution and Sales Area

Table 23. Players Dermatomycoses Drug Products Offered

Table 24. Dermatomycoses Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Dermatomycoses Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Dermatomycoses Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Dermatomycoses Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Dermatomycoses Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Dermatomycoses Drug Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Dermatomycoses Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Dermatomycoses Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Dermatomycoses Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)

Table 36. Americas Dermatomycoses Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Dermatomycoses Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Dermatomycoses Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)

Table 40. Americas Dermatomycoses Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)

Table 42. Americas Dermatomycoses Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Dermatomycoses Drug Sales by Region (2017-2022) & (K Units)

Table 44. APAC Dermatomycoses Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Dermatomycoses Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Dermatomycoses Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)

Table 48. APAC Dermatomycoses Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)

Table 50. APAC Dermatomycoses Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)

Table 52. Europe Dermatomycoses Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Dermatomycoses Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Dermatomycoses Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)

Table 56. Europe Dermatomycoses Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)

Table 58. Europe Dermatomycoses Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Dermatomycoses Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Dermatomycoses Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Dermatomycoses Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Dermatomycoses Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Dermatomycoses Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Dermatomycoses Drug

Table 68. Key Market Challenges & Risks of Dermatomycoses Drug

Table 69. Key Industry Trends of Dermatomycoses Drug

Table 70. Dermatomycoses Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Dermatomycoses Drug Distributors List

Table 73. Dermatomycoses Drug Customer List

Table 74. Global Dermatomycoses Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Dermatomycoses Drug Sales Market Forecast by Region

Table 76. Global Dermatomycoses Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Dermatomycoses Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Dermatomycoses Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Dermatomycoses Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Dermatomycoses Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Dermatomycoses Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Dermatomycoses Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Dermatomycoses Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Dermatomycoses Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Dermatomycoses Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Dermatomycoses Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Dermatomycoses Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Dermatomycoses Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Dermatomycoses Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Dermatomycoses Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Dermatomycoses Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Dermatomycoses Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Dermatomycoses Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Anacor Pharmaceuticals Inc Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product Offered

Table 96. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Anacor Pharmaceuticals Inc Main Business

Table 98. Anacor Pharmaceuticals Inc Latest Developments

Table 99. Biolab Farmaceutica Ltda Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Biolab Farmaceutica Ltda Dermatomycoses Drug Product Offered

Table 101. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Biolab Farmaceutica Ltda Main Business

Table 103. Biolab Farmaceutica Ltda Latest Developments

Table 104. Blueberry Therapeutics Ltd Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Blueberry Therapeutics Ltd Dermatomycoses Drug Product Offered

Table 106. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Blueberry Therapeutics Ltd Main Business

Table 108. Blueberry Therapeutics Ltd Latest Developments

Table 109. Daewoong Pharmaceutical Co Ltd Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product Offered

Table 111. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Daewoong Pharmaceutical Co Ltd Main Business

Table 113. Daewoong Pharmaceutical Co Ltd Latest Developments

Table 114. Dermala Inc Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Dermala Inc Dermatomycoses Drug Product Offered

Table 116. Dermala Inc Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Dermala Inc Main Business

Table 118. Dermala Inc Latest Developments

Table 119. Helix BioMedix Inc Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Helix BioMedix Inc Dermatomycoses Drug Product Offered

Table 121. Helix BioMedix Inc Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Helix BioMedix Inc Main Business

Table 123. Helix BioMedix Inc Latest Developments

Table 124. Novan Inc Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Novan Inc Dermatomycoses Drug Product Offered

Table 126. Novan Inc Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Novan Inc Main Business

Table 128. Novan Inc Latest Developments

Table 129. Sol-Gel Technologies Ltd Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Sol-Gel Technologies Ltd Dermatomycoses Drug Product Offered

Table 131. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Sol-Gel Technologies Ltd Main Business

Table 133. Sol-Gel Technologies Ltd Latest Developments

Table 134. TGV-Laboratories Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. TGV-Laboratories Dermatomycoses Drug Product Offered

Table 136. TGV-Laboratories Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. TGV-Laboratories Main Business

Table 138. TGV-Laboratories Latest Developments

Table 139. Viamet Pharmaceuticals Inc Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Viamet Pharmaceuticals Inc Dermatomycoses Drug Product Offered

Table 141. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Viamet Pharmaceuticals Inc Main Business

Table 143. Viamet Pharmaceuticals Inc Latest Developments

Table 144. Vyome Biosciences Pvt Ltd Basic Information, Dermatomycoses Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product Offered

Table 146. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Vyome Biosciences Pvt Ltd Main Business

Table 148. Vyome Biosciences Pvt Ltd Latest Developments

List of Figures

Figure 1. Picture of Dermatomycoses Drug

Figure 2. Dermatomycoses Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dermatomycoses Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Dermatomycoses Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Dermatomycoses Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of BB-2603

Figure 10. Product Picture of Clotrimazole

Figure 11. Product Picture of Dapaconazole

Figure 12. Product Picture of Others

Figure 13. Global Dermatomycoses Drug Sales Market Share by Type in 2021

Figure 14. Global Dermatomycoses Drug Revenue Market Share by Type (2017-2022)

Figure 15. Dermatomycoses Drug Consumed in Hospital

Figure 16. Global Dermatomycoses Drug Market: Hospital (2017-2022) & (K Units)

Figure 17. Dermatomycoses Drug Consumed in Clinic

Figure 18. Global Dermatomycoses Drug Market: Clinic (2017-2022) & (K Units)

Figure 19. Dermatomycoses Drug Consumed in Others

Figure 20. Global Dermatomycoses Drug Market: Others (2017-2022) & (K Units)

Figure 21. Global Dermatomycoses Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Dermatomycoses Drug Revenue Market Share by Application in 2021

Figure 23. Dermatomycoses Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Dermatomycoses Drug Revenue Market Share by Company in 2021

Figure 25. Global Dermatomycoses Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Dermatomycoses Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Dermatomycoses Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Dermatomycoses Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Dermatomycoses Drug Sales 2017-2022 (K Units)

Figure 30. Americas Dermatomycoses Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Dermatomycoses Drug Sales 2017-2022 (K Units)

Figure 32. APAC Dermatomycoses Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Dermatomycoses Drug Sales 2017-2022 (K Units)

Figure 34. Europe Dermatomycoses Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Dermatomycoses Drug Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Dermatomycoses Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Dermatomycoses Drug Sales Market Share by Country in 2021

Figure 38. Americas Dermatomycoses Drug Revenue Market Share by Country in 2021

Figure 39. United States Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Dermatomycoses Drug Sales Market Share by Region in 2021

Figure 44. APAC Dermatomycoses Drug Revenue Market Share by Regions in 2021

Figure 45. China Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Dermatomycoses Drug Sales Market Share by Country in 2021

Figure 52. Europe Dermatomycoses Drug Revenue Market Share by Country in 2021

Figure 53. Germany Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Dermatomycoses Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Dermatomycoses Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Dermatomycoses Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Dermatomycoses Drug in 2021

Figure 66. Manufacturing Process Analysis of Dermatomycoses Drug

Figure 67. Industry Chain Structure of Dermatomycoses Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles